Well maybe, just maybe we will have new data to present at...

Well maybe, just maybe we will have new data to present at conference from the Dep Irinotecan trial, remembering also this is also a networking event.

• Positive interim clinical data from Starpharma’s Phase 1/2 clinical trial of DEP^® irinotecan will be presented at a key international oncology conference that will take place in Boston, US, from 11 to 15 October 2023.

Need to bare in mind the data presented in October 2023 is several months old

Obviously there has been a lot of further data from the mono and combo study

ASCO Annual Meeting
The ASCO Annual Meeting is considered the premiere international forum for the presentation of scientific research and state-of-the-art education in clinical oncology. The five-day event attracts 30,000 attendees from around the world. Clinical trial results and updates presented at ASCO's Annual Meeting represent the significant progress made each year in the fight against cancer.